TELEMEDICINE AND MOBILE HEALTH IN TYPE 2 DIABETES SELF-MANAGEMENT: EFFECTIVENESS, SAFETY, AND THE CASE FOR HYBRID CARE
DOI:
https://doi.org/10.31435/ijitss.3(51).2026.6305Keywords:
Type 2 Diabetes Mellitus, Telemedicine, Mobile Health, Digital Health, Glycated Hemoglobin, Hybrid CareAbstract
Background: Type 2 diabetes mellitus requires sustained self-management and regular clinical assessment. Telemedicine and mobile health may improve continuity of care, although their value varies with service design, patient capability, and professional oversight.
Aim: To critically evaluate the effectiveness, safety, equity, and appropriate clinical use of telemedicine and mobile health in adults with type 2 diabetes mellitus.
Material and Methods: Peer-reviewed literature was identified in PubMed, with Google Scholar used for supplementary citation searching. Current clinical standards, systematic reviews, meta-analyses, randomized trials, safety assessments, and qualitative studies were included in a narrative synthesis.
Results: Digital interventions produced modest average reductions in glycated hemoglobin, but results varied substantially between studies and were neutral in a primary-care meta-analysis. Benefit was more evident in patients with higher baseline HbA1c and in services combining monitoring with medication adjustment or responsive professional feedback. Relevant risks included digital exclusion, unvalidated dosing advice, unclear clinical responsibility, additional professional workload, and omission of necessary physical examination.
Conclusions: Telemedicine should complement rather than replace direct care. A hybrid model integrating remote monitoring with defined escalation procedures, accountable professional review, and periodic or clinically indicated face-to-face assessment is the most defensible approach.
References
Alfarwan, N., Hodkinson, A., Panagioti, M., Hassan, L., & Kontopantelis, E. (2024). Clinical and cost-effectiveness of telemedicine among patients with type 2 diabetes in primary care: A systematic review and meta-analysis. Diabetic Medicine, 41(8), e15343. https://doi.org/10.1111/dme.15343
American Diabetes Association Professional Practice Committee for Diabetes. (2026a). 4. Comprehensive medical evaluation and assessment of comorbidities: Standards of care in diabetes—2026. Diabetes Care, 49(Suppl. 1), S61–S88. https://doi.org/10.2337/dc26-S004
American Diabetes Association Professional Practice Committee for Diabetes. (2026b). 2. Diagnosis and classification of diabetes: Standards of care in diabetes—2026. Diabetes Care, 49(Suppl. 1), S27–S49. https://doi.org/10.2337/dc26-S002
Bingham, J. M., Black, M., Anderson, E. J., Li, Y., Toselli, N., Fox, S., Martin, J. R., Axon, D. R., & Silva-Almodóvar, A. (2021). Impact of telehealth interventions on medication adherence for patients with type 2 diabetes, hypertension, and/or dyslipidemia: A systematic review. The Annals of Pharmacotherapy, 55(5), 637–649. https://doi.org/10.1177/1060028020950726
Cao, D. X., Tran, R. J. C., Yamzon, J., Stewart, T. L., & Hernandez, E. A. (2022). Effectiveness of telepharmacy diabetes services: A systematic review and meta-analysis. American Journal of Health-System Pharmacy, 79(11), 860–872. https://doi.org/10.1093/ajhp/zxac070
Crowley, M. J., Tarkington, P. E., Bosworth, H. B., Jeffreys, A. S., Coffman, C. J., Maciejewski, M. L., Steinhauser, K., Smith, V. A., Dar, M. S., Fredrickson, S. K., Mundy, A. C., Strawbridge, E. M., Marcano, T. J., Overby, D. L., Majette Elliott, N. T., Danus, S., & Edelman, D. (2022). Effect of a comprehensive telehealth intervention vs telemonitoring and care coordination in patients with persistently poor type 2 diabetes control: A randomized clinical trial. JAMA Internal Medicine, 182(9), 943–952. https://doi.org/10.1001/jamainternmed.2022.2947
Donaghy, E., Atherton, H., Hammersley, V., McNeilly, H., Bikker, A., Robbins, L., Campbell, J., & McKinstry, B. (2019). Acceptability, benefits, and challenges of video consulting: A qualitative study in primary care. British Journal of General Practice, 69(686), e586–e594. https://doi.org/10.3399/bjgp19X704141
Eberle, C., & Stichling, S. (2021). Clinical improvements by telemedicine interventions managing type 1 and type 2 diabetes: Systematic meta-review. Journal of Medical Internet Research, 23(2), e23244. https://doi.org/10.2196/23244
Faruque, L. I., Wiebe, N., Ehteshami-Afshar, A., Liu, Y., Dianati-Maleki, N., Hemmelgarn, B. R., Manns, B. J., Tonelli, M., & Alberta Kidney Disease Network. (2017). Effect of telemedicine on glycated hemoglobin in diabetes: A systematic review and meta-analysis of randomized trials. CMAJ, 189(9), E341–E364. https://doi.org/10.1503/cmaj.150885
Fleming, G. A., Petrie, J. R., Bergenstal, R. M., Holl, R. W., Peters, A. L., & Heinemann, L. (2020). Diabetes digital app technology: Benefits, challenges, and recommendations. A consensus report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group. Diabetologia, 63(2), 229–241. https://doi.org/10.1007/s00125-019-05034-1
Franc, S., Daoudi, A., Mounier, S., Boucherie, B., Dardari, D., Laroye, H., Neraud, B., Requeda, E., Canipel, L., & Charpentier, G. (2011). Telemedicine and diabetes: Achievements and prospects. Diabetes & Metabolism, 37(6), 463–476. https://doi.org/10.1016/j.diabet.2011.06.006
Gerber, B. S., Biggers, A., Tilton, J. J., Smith Marsh, D. E., Lane, R., Mihailescu, D., Lee, J., & Sharp, L. K. (2023). Mobile health intervention in patients with type 2 diabetes: A randomized clinical trial. JAMA Network Open, 6(9), e2333629. https://doi.org/10.1001/jamanetworkopen.2023.33629
Hamasaki, H. (2022). Patient satisfaction with telemedicine in adults with diabetes: A systematic review. Healthcare, 10(9), 1677. https://doi.org/10.3390/healthcare10091677
Hangaard, S., Laursen, S. H., Andersen, J. D., Kronborg, T., Vestergaard, P., Hejlesen, O., & Udsen, F. W. (2023). The effectiveness of telemedicine solutions for the management of type 2 diabetes: A systematic review, meta-analysis, and meta-regression. Journal of Diabetes Science and Technology, 17(3), 794–825. https://doi.org/10.1177/19322968211064633
He, Q., Zhao, X., Wang, Y., Xie, Q., & Cheng, L. (2022). Effectiveness of smartphone application-based self-management interventions in patients with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials. Journal of Advanced Nursing, 78(2), 348–362. https://doi.org/10.1111/jan.14993
Huckvale, K., Adomaviciute, S., Prieto, J. T., Leow, M. K., & Car, J. (2015). Smartphone apps for calculating insulin dose: A systematic assessment. BMC Medicine, 13, 106. https://doi.org/10.1186/s12916-015-0314-7
Jiang, Y., Ramachandran, H. J., Teo, J. Y. C., Leong, F. L., Lim, S. T., Nguyen, H. D., & Wang, W. (2022). Effectiveness of a nurse-led smartphone-based self-management programme for people with poorly controlled type 2 diabetes: A randomized controlled trial. Journal of Advanced Nursing, 78(4), 1154–1165. https://doi.org/10.1111/jan.15178
Kerr, D., Ahn, D., Waki, K., Wang, J., Breznen, B., & Klonoff, D. C. (2024). Digital interventions for self-management of type 2 diabetes mellitus: Systematic literature review and meta-analysis. Journal of Medical Internet Research, 26, e55757. https://doi.org/10.2196/55757
Kim, G., Kim, S., Lee, Y. B., Jin, S. M., Hur, K. Y., & Kim, J. H. (2024). A randomized controlled trial of an app-based intervention on physical activity and glycemic control in people with type 2 diabetes. BMC Medicine, 22(1), 185. https://doi.org/10.1186/s12916-024-03408-w
Lam, K., Lu, A. D., Shi, Y., & Covinsky, K. E. (2020). Assessing telemedicine unreadiness among older adults in the United States during the COVID-19 pandemic. JAMA Internal Medicine, 180(10), 1389–1391. https://doi.org/10.1001/jamainternmed.2020.2671
Lau, D., Manca, D. P., Singh, P., Perry, T., Olu-Jordan, I., Ryan Zhang, J., Rahim, G., Hagen, E. M., & Yeung, R. O. (2024). The effectiveness of continuous glucose monitoring with remote telemonitoring-enabled virtual educator visits in adults with non-insulin dependent type 2 diabetes: A randomized trial. Diabetes Research and Clinical Practice, 217, 111899. https://doi.org/10.1016/j.diabres.2024.111899
Lee, E. Y., Cha, S. A., Yun, J. S., Lim, S. Y., Lee, J. H., Ahn, Y. B., Yoon, K. H., Hyun, M. K., & Ko, S. H. (2022). Efficacy of personalized diabetes self-care using an electronic medical record-integrated mobile app in patients with type 2 diabetes: 6-month randomized controlled trial. Journal of Medical Internet Research, 24(7), e37430. https://doi.org/10.2196/37430
Lee, Y. B., Kim, G., Jun, J. E., Park, H., Lee, W. J., Hwang, Y. C., & Kim, J. H. (2023). An integrated digital health care platform for diabetes management with AI-based dietary management: 48-week results from a randomized controlled trial. Diabetes Care, 46(5), 959–966. https://doi.org/10.2337/dc22-1929
Lim, S. L., Ong, K. W., Johal, J., Han, C. Y., Yap, Q. V., Chan, Y. H., Chooi, Y. C., Zhang, Z. P., Chandra, C. C., Thiagarajah, A. G., & Khoo, C. M. (2021). Effect of a smartphone app on weight change and metabolic outcomes in Asian adults with type 2 diabetes: A randomized clinical trial. JAMA Network Open, 4(6), e2112417. https://doi.org/10.1001/jamanetworkopen.2021.12417
Mayberry, L. S., Lyles, C. R., Oldenburg, B., Osborn, C. Y., Parks, M., & Peek, M. E. (2019). mHealth interventions for disadvantaged and vulnerable people with type 2 diabetes. Current Diabetes Reports, 19(12), 148. https://doi.org/10.1007/s11892-019-1280-9
Mokaya, M., Kyallo, F., Vangoitsenhoven, R., & Matthys, C. (2022). Clinical and patient-centered implementation outcomes of mHealth interventions for type 2 diabetes in low- and middle-income countries: A systematic review. International Journal of Behavioral Nutrition and Physical Activity, 19(1), 1. https://doi.org/10.1186/s12966-021-01238-0
Moschonis, G., Siopis, G., Jung, J., Eweka, E., Willems, R., Kwasnicka, D., Asare, B. Y., Kodithuwakku, V., Verhaeghe, N., Vedanthan, R., Annemans, L., Oldenburg, B., Manios, Y., & DigiCare4You Consortium. (2023). Effectiveness, reach, uptake, and feasibility of digital health interventions for adults with type 2 diabetes: A systematic review and meta-analysis of randomised controlled trials. The Lancet Digital Health, 5(3), e125–e143. https://doi.org/10.1016/S2589-7500(22)00233-3
Nayak, A., Vakili, S., Nayak, K., Nikolov, M., Chiu, M., Sosseinheimer, P., Talamantes, S., Testa, S., Palanisamy, S., Giri, V., & Schulman, K. (2023). Use of voice-based conversational artificial intelligence for basal insulin prescription management among patients with type 2 diabetes: A randomized clinical trial. JAMA Network Open, 6(12), e2340232. https://doi.org/10.1001/jamanetworkopen.2023.40232
Oh, S. S., Kim, K. A., Kim, M., Oh, J., Chu, S. H., & Choi, J. (2021). Measurement of digital literacy among older adults: Systematic review. Journal of Medical Internet Research, 23(2), e26145. https://doi.org/10.2196/26145
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023). Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clinical Chemistry, 69(8), 808–868. https://doi.org/10.1093/clinchem/hvad080
Sitter, K. E., Wong, D. H., Bolton, R. E., & Vimalananda, V. G. (2022). Clinical appropriateness of telehealth: A qualitative study of endocrinologists’ perspectives. Journal of the Endocrine Society, 6(8), bvac089. https://doi.org/10.1210/jendso/bvac089
Young, H. M., Miyamoto, S., Dharmar, M., & Tang-Feldman, Y. (2020). Nurse coaching and mobile health compared with usual care to improve diabetes self-efficacy for persons with type 2 diabetes: Randomized controlled trial. JMIR mHealth and uHealth, 8(3), e16665. https://doi.org/10.2196/16665
Zhai, Y. K., Zhu, W. J., Cai, Y. L., Sun, D. X., & Zhao, J. (2014). Clinical- and cost-effectiveness of telemedicine in type 2 diabetes mellitus: A systematic review and meta-analysis. Medicine, 93(28), e312. https://doi.org/10.1097/MD.0000000000000312
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Radoslaw Sciepuro, Dawid Cyls, Marta Czarnowska, Nina Czarnowska
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
How to Cite
